Francesca Cottino

1.4k total citations
11 papers, 426 citations indexed

About

Francesca Cottino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Francesca Cottino has authored 11 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Francesca Cottino's work include Colorectal Cancer Treatments and Studies (9 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Francesca Cottino is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Francesca Cottino collaborates with scholars based in Italy, Belarus and United States. Francesca Cottino's co-authors include Andrea Bertotti, Livio Trusolino, Giorgia Migliardi, Simonetta M. Leto, Francesco Galimi, Samuel A. Jacobs, Wei Shen, Adam C. Searleman, Shyam M. Kavuri and Ron Bose and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Francesca Cottino

11 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Cottino Italy 5 283 112 105 102 85 11 426
Sarah Croessmann United States 13 219 0.8× 217 1.9× 136 1.3× 239 2.3× 68 0.8× 26 492
P.N. Munster United States 12 336 1.2× 307 2.7× 119 1.1× 79 0.8× 72 0.8× 18 584
Lucia Raimondo Italy 8 185 0.7× 204 1.8× 105 1.0× 55 0.5× 36 0.4× 15 387
Christine Unitt United States 8 325 1.1× 287 2.6× 55 0.5× 95 0.9× 122 1.4× 9 556
Lee Trani United States 6 116 0.4× 118 1.1× 56 0.5× 64 0.6× 90 1.1× 6 276
Austin Dulak United States 11 162 0.6× 440 3.9× 103 1.0× 256 2.5× 51 0.6× 16 675
Youjin Kim South Korea 14 452 1.6× 150 1.3× 444 4.2× 168 1.6× 41 0.5× 28 689
Lida Pacaud United States 12 520 1.8× 245 2.2× 111 1.1× 45 0.4× 66 0.8× 56 621
G Steger Austria 4 200 0.7× 86 0.8× 40 0.4× 115 1.1× 84 1.0× 6 345
Brett H. Simmons United States 8 201 0.7× 257 2.3× 151 1.4× 124 1.2× 59 0.7× 9 488

Countries citing papers authored by Francesca Cottino

Since Specialization
Citations

This map shows the geographic impact of Francesca Cottino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Cottino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Cottino more than expected).

Fields of papers citing papers by Francesca Cottino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Cottino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Cottino. The network helps show where Francesca Cottino may publish in the future.

Co-authorship network of co-authors of Francesca Cottino

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Cottino. A scholar is included among the top collaborators of Francesca Cottino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Cottino. Francesca Cottino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Leto, Simonetta M., Francesco Sassi, Eugenia R. Zanella, et al.. (2023). Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer. Clinical Cancer Research. 29(6). 1102–1113. 3 indexed citations
2.
Beekhof, Robin, Andrea Bertotti, Franziska Böttger, et al.. (2023). Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer. Science Translational Medicine. 15(709). eabm3687–eabm3687. 17 indexed citations
3.
Merlino, G., Mario Bigioni, Patrizia Tunici, et al.. (2021). 489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts. Annals of Oncology. 32. S573–S573. 2 indexed citations
4.
Belli, Valentina, Nunzia Matrone, Stefania Napolitano, et al.. (2019). Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models. Journal of Experimental & Clinical Cancer Research. 38(1). 236–236. 28 indexed citations
5.
Cottino, Francesca, Marco Busso, Francesco Guerrera, et al.. (2017). Prospective generation of PDTX (patient derived tumor xenografts) and molecular profiling of NSCLC (non small cell lung cancer). Annals of Oncology. 28. vi58–vi58. 1 indexed citations
6.
Lupo, Barbara, Paolo Armando Gagliardi, Francesco Sassi, et al.. (2017). Abstract LB-293: Targeting the PI3K pathway to intercept cetuximab tolerance in metastatic colorectal cancer. Cancer Research. 77(13_Supplement). LB–293. 1 indexed citations
7.
Sartore‐Bianchi, Andrea, Silvia Marsoni, Livio Trusolino, et al.. (2016). Pertuzumab and trastuzumab-emtansine in HER2 positive metastatic colorectal cancer: the HERACLES B TRIAL. Annals of Oncology. 27. iv47–iv47. 1 indexed citations
8.
Trusolino, Livio, Andrea Bertotti, Sara Lonardi, et al.. (2016). Abstract CT082: Pertuzumab and trastuzumab-emtansine in HER2-positive colorectal cancer: the HERACLES B trial. Cancer Research. 76(14_Supplement). CT082–CT082. 3 indexed citations
9.
Kavuri, Shyam M., Naveen Jain, Francesco Galimi, et al.. (2015). HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment. Cancer Discovery. 5(8). 832–841. 218 indexed citations
10.
Zanella, Eugenia R., Francesco Galimi, Francesco Sassi, et al.. (2015). IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. Science Translational Medicine. 7(272). 272ra12–272ra12. 70 indexed citations
11.
Vaisitti, Tiziana, Semra Aydin, Davide Rossi, et al.. (2010). CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia. 24(5). 958–969. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026